Corcept Therapeutics Inc’s filing revealed that its Chief Development Officer Guyer William unloaded Company’s shares for reported $1.41 million on Sep 02 ’25. In the deal valued at $70.49 per share,20,000 shares were sold. As a result of this transaction, Guyer William now holds 5,487 shares worth roughly $0.39 million.
Then, Lyon Joseph Douglas sold 5,000 shares, generating $351,247 in total proceeds. Upon selling the shares at $70.25, the insider now owns 10,066 shares.
Before that, Maduck Sean sold 20,000 shares. Corcept Therapeutics Inc shares valued at $1,409,828 were divested by the insider at a price of $70.49 per share. As a result of the transaction, Maduck Sean now holds 7,681 shares, worth roughly $0.55 million.
Truist upgraded its Corcept Therapeutics Inc [CORT] rating to a Buy from a a Hold in a research note published on November 06, 2023; the price target was increased to $38 from $29. A number of analysts have revised their coverage, including SVB Securities’s analysts, who began to cover the stock in mid April with a ‘”a Market perform”‘ rating. Piper Sandler began covering CORT with “an Overweight” recommendation on April 04, 2023. Jefferies revised its rating on February 15, 2023. It rated CORT as “a Hold” which previously was an “a Buy”.
Price Performance Review of CORT
On Tuesday, Corcept Therapeutics Inc [NASDAQ:CORT] saw its stock jump 0.70% to $71.73. Over the last five days, the stock has gained 0.49%. Corcept Therapeutics Inc shares have risen nearly 110.35% since the year began. Nevertheless, the stocks have risen 42.35% over the past one year. While a 52-week high of $117.33 was reached on 03/31/25, a 52-week low of $34.25 was recorded on 01/13/25.
Levels Of Support And Resistance For CORT Stock
The 24-hour chart illustrates a support level at 70.64, which if violated will result in even more drops to 69.56. On the upside, there is a resistance level at 72.50. A further resistance level may holdings at 73.28.
How much short interest is there in Corcept Therapeutics Inc?
A steep rise in short interest was recorded in Corcept Therapeutics Inc stocks on 2025-08-15, dropping by -0.63 million shares to a total of 10.59 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-15 was 11.22 million shares. There was a decline of -5.97%, which implies that there is a negative sentiment for the stock.
